Investment details
Entry
Staff
50Location
IrelandWe are very pleased to be involved in FIRE1, a company with an experienced team that is developing a new monitoring device for heart failure. This is a market with growing unmet needs, as cardiac disease is currently the world’s leading cause of death. This financing represents one of the bigger medtech transactions in Europe over the last months and is supported by an outstanding investor syndicate.
Michaël Vlemmix
Partner
Partnership Gimv
Gimv's decision to partner with FIRE1 is driven by the immense potential in a rapidly expanding market, characterised by increasingly unmet needs, particularly in the context of cardiac disease – a leading global cause of mortality. The financial support extended to FIRE1 is empowering the company to continue the development and enhancement of their innovative remote monitoring solution. This technology is poised to make significant strides in improving the overall outcomes and quality of life for individuals suffering from heart failure.
